Carbohydrate dose influences liver and muscle glycogen oxidation and performance during prolonged exercise by King, Andy J. et al.
ORIGINAL RESEARCH
Carbohydrate dose influences liver and muscle glycogen
oxidation and performance during prolonged exercise
Andy J. King1 , John P. O’Hara1 , Douglas J. Morrison2, Tom Preston2 & Roderick F. G. J. King1
1 Research Institute for Sport, Physical Activity and Leisure, Leeds Beckett University, Leeds, United Kingdom
2 Scottish Universities Environmental Research Centre, East Kilbride, United Kingdom
Keywords
Carbohydrate ingestion, exercise,
metabolism, muscle glycogen, stable isotope.
Correspondence
Andy J. King, Carnegie School of Sport,
Fairfax Hall, Leeds Beckett University, Leeds,
LS6 3QT, United Kingdom.
Tel: +44 113 812 6569
E-mail: a.k.king@leedsbeckett.ac.uk
Funding Information
No funding information provided.
Received: 29 November 2017; Revised: 4
December 2017; Accepted: 5 December
2017
doi: 10.14814/phy2.13555
Physiol Rep, 6 (1), 2018, e13555,
https://doi.org/10.14814/phy2.13555
Abstract
This study investigated the effect of carbohydrate (CHO) dose and composi-
tion on fuel selection during exercise, specifically exogenous and endogenous
(liver and muscle) CHO oxidation. Ten trained males cycled in a double-blind
randomized order on 5 occasions at 77% _VO2max for 2 h, followed by a
30-min time-trial (TT) while ingesting either 60 gh1 (LG) or 75 gh1 13C-
glucose (HG), 90 gh1 (LGF) or 112.5 gh1 13C-glucose-13C-fructose ([2:1]
HGF) or placebo. CHO doses met or exceed reported intestinal transporter
saturation for glucose and fructose. Indirect calorimetry and stable mass iso-
tope [13C] tracer techniques were utilized to determine fuel use. TT perfor-
mance was 93% “likely/probable” to be improved with LGF compared with
the other CHO doses. Exogenous CHO oxidation was higher for LGF and
HGF compared with LG and HG (ES > 1.34, P < 0.01), with the relative con-
tribution of LGF (24.5  5.3%) moderately higher than HGF (20.6  6.2%,
ES = 0.68). Increasing CHO dose beyond intestinal saturation increased abso-
lute (29.2  28.6 gh1, ES = 1.28, P = 0.06) and relative muscle glycogen
utilization (9.2  6.9%, ES = 1.68, P = 0.014) for glucose-fructose ingestion.
Absolute muscle glycogen oxidation between LG and HG was not significantly
different, but was moderately higher for HG (ES = 0.60). Liver glycogen oxida-
tion was not significantly different between conditions, but absolute and rela-
tive contributions were moderately attenuated for LGF (19.3  9.4 gh1,
6.8  3.1%) compared with HGF (30.5  17.7 gh1, 10.1  4.0%, ES = 0.79
& 0.98). Total fat oxidation was suppressed in HGF compared with all other
CHO conditions (ES > 0.90, P = 0.024–0.17). In conclusion, there was no lin-
ear dose response for CHO ingestion, with 90 gh1 of glucose-fructose being
optimal in terms of TT performance and fuel selection.
Introduction
During prolonged exercise, endogenous carbohydrate
(CHO) and fat act as metabolic substrates to provide
energy to the working muscle (Van Loon et al. 2001),
with both intra and extra-myocellular sources essential
for strenuous exercise. The protection of finite reserves of
liver and muscle glycogen, by provision of exogenous
sources of CHO just before and during exercise, may con-
tribute to a prolonged exercise performance, especially
where a high-intensity effort toward the end of exercise is
required. However, evidence of “sparing” glycogen with
exogenous CHO feeding has received equivocal support
(Stellingwerff and Cox 2014), indicating the mechanisms
behind the ergogenic benefit of CHO ingestion are likely
multi-factorial, but also sensitive to dose of CHO ingested
(Wallis et al. 2007; Smith et al. 2013).
The major rate-limiting step to exogenous CHO oxida-
tion appears to be the transport of hexoses across the
intestinal mucosa. Due to saturation of the glucose speci-
fic sodium dependent glucose transporter (SGLT1), glu-
cose has an upper oxidation rate of ~1.0–1.1 gmin1
during exercise (Jentjens et al. 2004b), whereas the addi-
tion of fructose can increase this to ~1.6–1.8 gmin1 by
exploiting the glucose transporter-5 (GLUT-5) intestinal
transporter (Adopo et al. 1994; Jentjens et al. 2004a;
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Jeukendrup et al. 2006). Therefore, to increase exogenous,
and attenuate endogenous CHO oxidation, it is recom-
mended that athletes ingest multiple transportable CHO
(MTC) in the form of glucose and fructose (GF) in a 2:1
ratio exceeding 1 gmin1. However, it should be noted
that relative to no CHO ingestion, a positive performance
effect can still be achieved with the ingestion of glucose
only (Jeukendrup 2014).
Relative to placebo, time to exhaustion has been
shown to improve by as much as 30% (Maughan et al.
1996; McConell et al. 1999) and time trial (TT) perfor-
mance by 5–12% (Hulston and Jeukendrup 2008; Trip-
plett et al. 2010; Baur et al. 2014) with CHO ingestion.
Smith et al. (2010) also found TT performance
improved with CHO dose; the largest improvement
(10.7%) found with ingestion of 60 gh1 glucose versus
lower 15 and 30 gh1 doses. However, this CHO inges-
tion did not exceed the saturation of SGLT1, which
appears to be the major rate limiting step to exogenous
CHO oxidation (Hawley et al. 1994; Shi et al. 1995). A
performance dose response with MTC has received less
attention compared with glucose only. Baur et al. (2014)
found no further performance benefit by increasing glu-
cose dose from 61.8 gh1 to 93 gh1, but a when an
isocaloric dose of GF was ingested, TT time was further
improved by 1.3%. In the one multiple dose study to
investigate MTC ingestion up to and beyond intestinal
saturation threshold, Smith et al. (2013) showed the per-
formance response to CHO ingestion may be curvilinear,
mathematically deriving an optimum dose for exercise
performance of 68–88 gh1.
Despite evidence that performance is generally
enhanced with exogenous CHO, the mechanism of its
effect is less clear (Stellingwerff and Cox 2014). Hulston
and Jeukendrup (2008) reported improved TT perfor-
mance with a concurrent reduction in endogenous glyco-
gen oxidation, but conflicting data also exist to this effect
(Rowlands et al. 2008; O’Brien and Rowlands 2011). It
appears that glycogen sparing is more likely to occur with
MTC ingestion (Jentjens et al. 2004a; Pfeiffer et al. 2011),
however, to date it seems that reported “whole body”
endogenous glycogen sparing may largely be due to
changes in liver glycogen oxidation (Gonzalez et al.
2015). Muscle glycogen has been shown to be spared dur-
ing prolonged running with ingestion of mixed CHO
solutions (Tsintzas et al. 1995, 1996) but evidence to this
effect is limited to studies quantifying muscle glycogen
oxidation with muscle biopsy analysis (Hargreaves et al.
1984; Yaspelkis et al. 1993; Tsintzas et al. 1995, 1996,
2001; Stellingwerff et al. 2007), where the quantification
of glycogen oxidation by this method may have some
limitations (Constantin-Teodosiu et al. 1996; Van
Thienen et al. 2014).
In the only dose-dependent investigation using stable
isotope tracers to report liver and muscle glycogen oxida-
tion concurrent with performance data, Smith et al.
(2010) found a higher glucose dose attenuated liver glyco-
gen oxidation and increased TT performance. However,
muscle glycogen oxidation tended to be slightly higher
(ES = 0.23) with the highest, 60 gh1 dose, a potentially
undesirable effect for prolonged exercise. Furthermore,
this study only investigated CHO doses below the
reported upper absorption rate for glucose ingestion, thus
potentially not maximizing intestinal CHO transport.
To date, there has been no investigation of a dose
response of MTC ingestion on liver and muscle glycogen
oxidation and the precise relationship between ingested
dose, glycogen sparing and exercise performance requires
further elucidation. Therefore, this study investigated the
relationship between the dose (60–112.5 gh1) of
ingested CHO (both glucose alone and coingestion of glu-
cose and fructose) on fuel use during 120 min of moder-
ate intensity cycling and subsequent time trial
performance. The use of indirect calorimetry combined
with 13C tracer techniques enabled the estimation of
exogenous and endogenous (liver and muscle) contribu-
tions to CHO oxidation. It was hypothesized that glu-
cose-fructose coingestion would improve time trial
performance and attenuate endogenous glycogen oxida-
tion to a greater extent than glucose only ingestion.
Methodology
Participants
Ten trained, healthy male cyclists volunteered to partici-
pate in this study. Participants were required to have
trained for >3 times per week in cycling specific training
for at least the last 2 years. Mean age, body mass, maxi-
mal oxygen uptake ( _VO2max), and maximal power output
(Wmax) were 30.7  7.9 year, 76.4  9.6 kg,
61.6  7.6 mLkg1min1, and 341.3  54.7 W, respec-
tively. Procedures and potential risks were explained
before the study and all participants provided written
informed consent. The study received institutional ethics
approval.
Preliminary testing
Preliminary testing consisted of two parts; a maximal
incremental cycle test to volitional exhaustion to deter-
mine Wmax and _VO2max, and a familiarization effort for
the 30-min time trial used to quantify exercise perfor-
mance in the subsequent experimental trials. This visit
was conducted 1 week before the first experimental trial
on a high-performance ergometer (SRM, Germany). In
2018 | Vol. 6 | Iss. 1 | e13555
Page 2
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion A. J. King et al.
line with the protocol of Kuipers et al. (1985), an initial
intensity of 100 W was completed for 5 min, after which
the workload increased by 50 W every 2.5 min until heart
rate reached 160 bmin1, after which it increased by
25 W every 2.5 min to volitional exhaustion. Wmax was
calculated from:
Wmax ¼ Plast þ Pend  ðt=150Þ (1)
Where Plast is the power output (W) of the last fully com-
pleted increment, Pend is the power output at volitional
exhaustion, and t is the time in seconds completed in the
last increment. In order to calculate the equivalent power
output for the experimental trials, a regression was
applied to the incremental test power outputs and the
end stage oxygen uptake ( _VO2). The power output at the
relevant percentage (77%) of _VO2max was calculated from
the slope and intercept these data according to:
Power output at x% _VO2max ¼ mx þ c (2)
Where m is the gradient of the _VO2 and power output
relationship, x the target % of _VO2max and c the y axis
intercept of the r _VO2 and power output relationship.
_VO2 and carbon dioxide production ( _VCO2) measure-
ments were made using an online gas analysis system
(Metalyser 3B, Cortex Biophysik GmbH, Germany). The
tripleV volume transducer was calibrated using a 3 L syr-
inge (Hans Rudolph Inc., Shawnee, KS, USA), and the
gas analyzers were calibrated using a two-point reference
gas calibration with room air and a gravimetric standard
gas mixture (BOC gases, Guildford, UK) of oxygen and
carbon dioxide in nitrogen (15% O2 and 5% CO2). The
test–retest reliability for _VO2 and _VCO2 (Lmin1) had
coefficients of variation in 3.32 and 1.33%, respectively.
Following a 20-min period of active and passive recov-
ery (10 min of each) after the maximal exercise test, par-
ticipants undertook a 30-min self-paced time trial (TT)
for familiarization purposes. The objective of the TT was
to complete the maximum amount of work possible
within 30 min. Participants were given no verbal encour-
agement during the test, but were able to see their current
power output and time completed/remaining.
Experimental design
Participants completed five experimental trials (separated
by 7 days) consisting of 120 min cycling at 77% _VO2max,
followed by a 30-min self-paced TT. During each trial
participants ingested 250 mL of one of five drinks solu-
tions every 15 min (starting at minute 15 into the exer-
cise protocol). Four CHO solutions, each enriched with
150 mg per 75 g CHO of a universally labeled (U–13C6)
glucose and/or fructose tracer (Sigma Aldrich, St Louis,
MO) providing 60 g (LG) and 75 g (HG) of glucose
(D-glucose; Thornton and Ross Ltd, Huddersfield, UK)
only, and 90 g (LGF) and 112.5 g (HGF) of glucose and
fructose (Danisco, Kettering, UK) (glucose-fructose ratio
2:1) were prescribed in a randomized, double-blind
design. Furthermore, a placebo trial (PLA) was also con-
ducted to determine the background appearance of 13CO2
in expired air and the metabolic response without CHO
ingestion. All formulations contained 26 mmolL1 of
NaCl (Saxa, Herts, UK), as well as artificial sweetener (as-
partame, Morrisons’ plc, Bradford, UK) to blind the par-
ticipants to each condition. The natural d13C abundance
of the stock glucose and fructose was measured by isotope
ratio mass spectrometry (IRMS, Isoprime, Cheadle, UK),
using L-fucose as an isotopic internal standard as previ-
ously described (Morrison et al. 2011). Glucose and fruc-
tose were determined to be 25.56& and 12.41&,
respectively. The final enrichment of d13C of the ingested
CHO solutions was; LG = +146.83  6.29&,
HG = +146.23  5.99&, LGF = +148.40  5.83& and
HGF = +147.20  4.27&. All d13C measurements are
quoted with reference to the internationally accepted
standard for carbon isotope measurements, Vienna Pee
Dee Belemnite (VPDB).
Diet and physical activity before testing
Participants recorded their food intake and physical activ-
ity during the 48 h before the first experimental trial and
were instructed to repeat the same diet and activity pat-
tern in the 48 h before subsequent trials. In the 24 h
before each experimental trial, participants were required
to not undertake any strenuous physical activity and
avoid alcohol and caffeine consumption. Furthermore,
participants were also asked to undergo an intense train-
ing session 48 h before each visit to deplete background
levels of 13C in glycogen (Harvey et al. 2007). Throughout
the experimental trials, participants were asked to refrain
from ingesting carbohydrates derived from plants which
utilize the C4 photosynthetic cycle, in which there is a
higher natural abundance of 13C (e.g., maize-derived sug-
ars). Each participant was provided with a list of foods to
avoid (Morrison et al. 2000). This precaution ensures that
background 13CO2 abundance was less likely to be per-
turbed from oxidation of endogenous and dietary sub-
strate stores from naturally “enriched” C4 origin. Before
each test, a standardized evening meal was consumed
10–12 h before arrival at the laboratory (total, 1443 kcal;
53% CHO, 17% fat, and 30% protein).
Experimental trials
After a 10–12 h overnight fast, participants reported to
the laboratory on each occasion between 0700 and 0900.
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Upon arrival at the laboratory, an in dwelling catheter
(20 gauge Introcan Safety, B. Braun Medical Ltd, Shef-
field, UK) was inserted into an antecubital vein for regu-
lar blood sampling. Over the next 10-min resting _VO2
and _VCO2 measurements were made using an online gas
analysis system (Metalyser 3B, Cortex, Germany), which
was calibrated following the manufacturer’s instructions.
For the measurement of 13CO2:
12CO2 in expired air at
rest, 12 mL Exetainers (SerCon Ltd, Crewe, UK) of
expired gas were collected in duplicate via a mixing
chamber (Jaeger, Germany).
Participants then completed 120 min of cycling at 77%
_VO2max on a high-performance ergometer. _VO2, _VCO2
and heart rate (HR) were measured every 15 min until
the end of exercise. Samples of expired gas for
13CO2:
12CO2 analysis were collected during the final 60 s
of each 15-minute period. Samples for the analysis of
plasma glucose, plasma lactate, serum insulin, serum-free
fatty acids were drawn every 15 min and for 13C plasma
glucose enrichment at 60, 90, and 120 min. Following
each completed 15-min period of data collection, one of
the 250 mL drink solutions was given to the participants,
who were instructed to consume the drink as quickly as
comfortably possible.
Analyses
Aliquots of plasma and serum prepared by centrifugation
were analyzed for selected metabolites. Glucose (glucose
oxidase kit; Instrumentation Laboratory, Monza, Italy,
inter assay CV: 5.4%, Intra assay CV: 2.6%) and lactate
(Lactate kit, Randox, County Antrim, UK, Inter CV:
4.7%, Intra CV: 2.9%) were analyzed by spectrophotome-
try (iLab 300 plus, ILab, UK). Insulin was analyzed using
a chemoiluminometric immunoassay (ADIVA Centaur,
Bayer diagnostics, Berkshire, UK, Inter CV: 3.2–4.6%,
Intra CV: 2.6–5.9%). Non-esterified free fatty acid content
of serum was analyzed by an acyl-CoA synthetase and
oxidase assay (NEFA-HR2, Wako Chemicals GmbH, Ger-
many, Inter assay CV: 1.5%).
The 13CO2:
12CO2 in expired air was determined by
IRMS. The isotopic ratio (13C:12C) is derived against
laboratory CO2 (itself calibrated against VPDB) from
the ion beam area ratio measurements with correction
of the small contribution of 12C16O17O at m/z 45,
(Craig (1957) correction). The 13C:12C in plasma glu-
cose was determined using LC-IRMS as described in
detail previously (Morrison et al. 2011). Briefly, plasma
samples were prepared by ultrafiltration (30,000 molec-
ular weight cut off tubes, Amicon Ultra 4, Millipore,
Watford, UK), with an internal standard added (L-
fucose, C6H12O5, Sigma Aldrich) and separated by liq-
uid chromatography to separate the glucose from other
constituents prior to “wet-oxidation” and IRMS analysis
of the resulting CO2.
Calculations
Total CHO and fat oxidation (gmin1) were computed
from _VO2 and _VCO2 (Lmin1) using the stoichiometric
equations of Frayn (1983), with protein oxidation during
exercise assumed to be negligible.
CHO ¼ ð4:55 _VCO2Þ  ð3:21 _VO2Þ (3)
Fat ¼ ð1:67 _VO2Þ  ð1:67 _VCO2Þ (4)
The isotopic enrichment of the ingested glucose and
fructose, (Rexo), and expired air (Rexp) was expressed in
standard d13C units (&) relative to VPDB (Craig, 1953).
Exogenous glucose oxidation derived from glucose and
the combined ingestion of glucose and fructose (CHOEX)
was computed using the following equation (Peronnet
et al. 1990), with the placebo condition establishing the
background 13CO2:
12CO2 during exercise.
CHOEXðg min1Þ ¼ _VCO2½ðRexp  Rref Þ=ðRexo  Rref Þ=k
(5)
Where _VCO is in Lmin1, Rexp is the isotopic composi-
tion of expired CO2, Rref is the isotopic composition of
expired CO2 at the same time point with ingestion of pla-
cebo, Rexo is the isotopic composition of the ingested
solution and k (0.747 Lg1) is the volume of CO2 pro-
vided by the complete oxidation of glucose.
Computations were made on the assumption that, in
response to exercise, 13C is not irreversibly lost in pools
of tricarboxylic acid cycle intermediates and/or bicarbon-
ate, and that 13CO2 recovery in expired gases was com-
plete or almost complete during exercise (Trimmer et al.
2001). Such computation has been shown to underesti-
mate exogenous oxidation rates at the beginning of exer-
cise because of the delay between 13CO2 production in
tissues and its exhalation (Pallikarakis et al. 1991). There-
fore, carbohydrate oxidation data are presented for the
second hour of the 2 h protocol to allow for a steady-
state condition of 13C in the bicarbonate pool to be
reached (Robert et al. 1987).
Based on the 13C isotopic composition of plasma glu-
cose (Rglu), the oxidation rate of plasma CHO was calcu-
lated (Peronnet et al. 1998):
Plasma CHOðg min1Þ ¼ _VCO2½ðRexp  Rref Þ=ðRglu
 Rref Þ=k (6)
Endogenous CHO oxidation was calculated as the dif-
ferences between total CHO oxidation and exogenous
2018 | Vol. 6 | Iss. 1 | e13555
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CHO oxidation. The oxidation rate of muscle glycogen
(gmin1), either directly or through the lactate shuttle
(Brooks 1986), was calculated by subtracting plasma glu-
cose oxidation from total carbohydrate oxidation (Equa-
tion 7). Finally, the amount of glucose released from the
liver was estimated as the difference between plasma glu-
cose and exogenous carbohydrate oxidation (Equation 8)
(Peronnet et al. 1998):
Muscle oxidation¼ total CHOoxidation
plasma glucose CHOoxidation (7)




The mean value observed for a given variable is presented
with the associated standard deviation (mean  SD) and
where comparisons between conditions made as the mean
difference with associated confidence limits at the 95%
level with Cohen’s d effect size [e.g., mean difference,
lower limit to upper limit (ES)] as recommended by
Hopkins et al. (2009).
In order to provide meaningful terms to the effec-
tiveness of CHO ingestion on exercise performance, a
probabilistic magnitude based inference analysis was
conducted to analyze the effect of CHO ingestion on
the mean power output during the 30-min TT. Using
the coefficient of variation (2.4%) of laboratory cycling
TT performance (Hopkins et al. 1999) and the smallest
worthwhile change in athletic performance (0.5 9 CV)
the smallest meaningful effect in power output between
conditions was computed to be 1.2%. The effect of
CHO ingestion was expressed as a percentage change
relative to placebo ingestion following back transforma-
tion of the mean of the natural logarithm of the power
outputs. The chance that the true value of the effect
was larger than the smallest meaningful effect on the
30-min TT were computed and qualitative terms
assigned (Hopkins et al. 2009): <1%, almost certainly
not; <5%, very unlikely; <25%, unlikely or probably
not; <50%, possibly not; >50%, possibly; >75%, likely
or probable; >95%, very likely; >99% almost certain.
For non-performance variables (heart rate, VO2, sub-
strate oxidation, and plasma glucose and lactate, serum-
free fatty acid, and insulin concentrations) where a
smallest worthwhile change is difficult to calculate, sta-
tistical comparisons were also made using a one-way
(dose) or two-way (dose 9 time) repeated measures
ANOVA with Bonferroni post hoc adjustment (SPSS
20, IBM, New York, USA) as well as Cohen’s d effect
sizes (ES). ES threshold values were set as 0.2. 0.6, 1.2,
2.0, and 4.0 for small, moderate, large, very large, and
extremely large effects, respectively (Hopkins et al.
2009).
Results
_VO2, _VCO2 and heart rate
_VO2 and _VCO2 did not significantly differ over time, that
is, between the first and second hour of the 2-h ride
(pooled data; ES = 0.16, P = 0.8 and P = 0.6, ES = 0.07,
respectively) or between conditions (P > 0.9, ES < 0.24,
Table 1). HR increased with time between the first and
second hour of the constant load rides in all conditions
(main effect P = 0.03, ES = 1.4), Table 1. HR was lower
for placebo compared with all CHO conditions for both
the first (moderate effect, ES = 0.691.13), and second
hour (large to very large effect, ES = 0.41–0.74) of cycling.
However, HR was only significantly lower for placebo
compared with HGF during the second hour of cycling
(P = 0.09, ES = 0.74).
Total carbohydrate and fat oxidation
Total energy expenditure was not significantly different
between conditions for the 2 h of continuous cycling
(PLA = 2217.0  286.5 kCal, LG = 2185.4  259.4 kCal,
HG = 2241.5  344.7 kCal, LGF = 2238.7  414.7 kCal,
HGF = 2237.2  375.3 kCal; P > 0.95, ES < 0.17). In
addition, no effects were seen between the first and second
hour of exercise P > 0.90, ES < 0.22, see Table 1 for data).
Absolute CHO oxidation was not significantly different
between conditions (P > 0.058) although total CHO oxi-
dation was highest throughout the 2-h ride (combined
first and second hour data) in HGF, producing moderate
to large effect sizes (ES = 0.78–1.37) compared with the
other conditions, which were all similar (ES
range = 0.22–0.58, Table 1). Absolute CHO oxidation
was also highest in HGF during the second hour of
cycling, albeit not significantly different between condi-
tions (P > 0.06). Total CHO oxidation was moderately
higher in HGF than LGF (ES = 0.79) and HG (ES = 0.87)
and produced large effect sizes compared with LG and
PLA (ES = 1.22 & 1.37). In contrast, absolute fat oxida-
tion during the 2-h ride was lower in HGF compared
with the other conditions (combined first and second
hour data), and remained lowest during the second hour
of cycling, despite there being no significant differences
between conditions (P > 0.192). Moderate to large effects
sizes were observed during the total 2 h ride (ES = 0.76–
1.30) and small to large effects were seen during the sec-
ond hour of cycling for absolute fat oxidation in HGF
compared with the other conditions (ES = 0.46–1.29).
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In addition, the relative contribution of total CHO oxi-
dation to the total energy yield (Fig. 2) during the second
hour of exercise was significantly higher in HGF com-
pared with PLA (difference = 16.6, 8.7–24.6%, P = 0.024,
ES = 1.88). Compared with the other CHO conditions,
this effect was moderate and significant (LG; 9.4, 4.4–
14.3%, P = 0.049, ES = 0.90. HG; 8.4, 4.5–12.3%,
P = 0.023, ES = 1.18) or large but nonsignificant (LGF;
9.6, 3.1–16.1%, P = 0.17, ES = 1.25). The increased rela-
tive CHO oxidation in HGF was associated with a con-
comitant moderate (and significant) or large (but
nonsignificant) reduction in the relative contribution of
fat to the energy yield compared with the other CHO
conditions (effect sizes, 95% confidence intervals and P
values the same as reported for CHO).
d 13CO2 in expired gas and d
13C in plasma
glucose
The d13CO2 in expired gas was similar between all condi-
tions at rest before exercise and the ingestion of placebo
or 13C enriched carbohydrate(s) (P < 0.52, ES < 0.50,
Fig. 1A). In PLA, the d13CO2 in expired gas increased
over time by 5.4& (ES = 1.95) from the start to the end
of exercise. These data were used as the background cor-
rection for the calculation of exogenous CHO and plasma
glucose oxidation for each CHO condition. The d13CO2
in expired gas significantly increased over time from the
start of exercise following the ingestion of all four 13C
enriched CHO conditions (Fig. 1A). Each condition
reached maximal values at 120 min, with LGF
(28.08  5.12&) and HGF (29.2  9.5&) being signifi-
cantly higher compared with LG (11.35  4.47&,
P = 0.001) and HG (14.94  5.97&; P = 0.0005–0.002),
with very large effects sizes (ES = 1.80–3.48). The d13CO2
in expired gas was also significantly higher for LGF and
HGF from 60 min onwards compared with LG and HG
(P < 0.05, ES = 0.65–3.48).
The isotopic composition of plasma glucose (d13C)
increased by 2.6& from 60 to 120 min of exercise with
ingestion of PLA (P = 0.09, ES = 0.9, Fig. 1B). In all
CHO conditions, there was a significant rise in plasma
d13C glucose between 60 and 90 min (P = 0.004–0.012,
ES = 1.11–1.40), except in HG where it was moderate but
nonsignificant (P = 0.25, ES = 0.61). Between 90 and
120 min, plasma d13C glucose remained similar for all
conditions (P > 0.32, ES = 0.11–0.21) except for a small,
nonsignificant rise in HG (P = 1.00, ES = 0.58). The iso-
topic composition of plasma glucose was highest for LGF
during the last hour of exercise, being moderately but not
significantly higher than LG (66.3  24.4&, P = 0.12,
ES = 0.71) and HGF (68.7  26.0&, P = 0.81,
ES = 0.60) at 60 min. There were moderate to large and
significant differences compared with LG at 90
(85.8  20.3&, P = 0.045, ES = 1.17) and 120 min
(86.0  19.8, P = 0.026, ES = 1.31), as well as HG at 90
(87.2  12.9, P = 0.04, ES = 1.44) and 120 min
(94.2  11.5, P = 0.034, ES = 1.14).
Table 1. Respiratory gas exchange, heart rate, and substrate utilization over the first and second hour of the 2 h of exercise at 77% _VO2max.
Data from the first h is presented in the top line of each variable, and the second hour in the bottom line.
Condition
Pla LG HG LGF HGF
HR (bmin1) 146  7 151  8 151  6 152  7 153  6
154  91 158  11 160  10 158  10 161  10
_VO2 (Lmin1) 3.49  0.45 3.61  0.56 3.52  0.58 3.57  0.69 3.61  0.67
3.62  0.42 3.63  0.49 3.49  0.42 3.62  0.64 3.71  0.63
_VCO2 (Lmin1) 3.18  0.41 3.22  0.47 3.19  0.50 3.15  0.62 3.22  0.56
3.18  0.37 3.23  0.38 3.16  0.36 3.25  0.60 3.31  0.31
RER 0.91  0.04 0.90  0.08 0.91  0.01 0.90  0.03 0.90  0.04
0.88  0.03 0.90  0.07 0.91  0.01 0.87  0.05 0.90  0.03
CHOox (g) 186.1  32.7 177.1  31.3 199.1  38.9 182.5  48.8 217.2  40.4
167.6  30.1 175.5  24.4 187.4  26.1 187.3  35.5 219.1  41.7
Fatox (g) 36.2  16.4 38.6  20.4 32.4  7.13 36.9  13.9 25.3  8.2
46.1  13.8 36.5  16.9 36.1  9.4 38.3  11.4 27.6  10.8
Energy expenditure (kCal) 1099.8  182.3 1088.4  151.7 1126.4  201.7 1106.1  220.1 1050.1  206.6
1117.2  129.3 1097.0  112.6 1115.2  149.1 1132.6  197.8 1187.1  211.6
Data are heart rate in bmin1, _VO2, _VCO2 in Lmin1, respiratory exchange ratio (RER), and CHO and fat oxidation in grams. All values are
mean  SD. N = 11.
1
Denotes PLA significantly lower than HGF.
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Sources of oxidized glucose (exogenous and
endogenous carbohydrate)
During the second hour of exercise, the rate of exogenous
CHO oxidation was higher with the ingestion of glucose-
fructose than with the ingestion of glucose only (Fig. 3)
and was highest with the ingestion of LGF, the highest
recorded value occurring after 120 min at
1.33  0.29 gmin1. This was significantly higher, with a
large effect size compared with both glucose only doses
(LG, 0.81  0.15 gmin1; P = 0.001, 0.52, 0.37–
0.68 gmin1, ES = 2.25, and HG, 0.88  0.23 gmin1;
P = 0.002, 0.45, 0.30–0.60 gmin1, ES = 1.72). However,
when the glucose-fructose dose was further increased,
ingestion of HGF produced a lower (small ES), but
nonsignificant maximal rate of oxidation
(1.23  0.3 gmin1; 0.10, 0.23–0.02 gmin1, P = 0.84,
ES = 0.36,) compared with LGF. Furthermore, the abso-
lute oxidation of exogenous CHO during the second hour
of cycling was significantly higher with glucose-fructose
ingestion compared with glucose only (Table 2;
P = 0.001–0.037, ES = 1.10–1.87). Total exogenous CHO
oxidation in the second hour was also higher with LGF
compared with HGF, but this effect was small and not
significant (see Table 2 for statistical data). Despite there
being only a small difference between LGF and HGF in
absolute terms, the relative contribution of exogenous
oxidation to the total energy yield showed a moderate and
close to significant reduction for HGF compared with
LGF during the second hour of exercise (3.7, 1.3 to 6.1%,
P = 0.06, ES = 0.68). The relative contribution from both
glucose-fructose doses to energy expenditure was signifi-
cantly greater than with glucose only (8.7, 6.3–11.0%
increase between LG & LGF, P = 0.001, ES = 1.78; 5.4,
2.5–8.3% increase between HG and HGF, P = 0.031,
ES = 0.99, Fig. 2). However, as with the increase in glu-
cose-fructose dose (LGF to HGF) a linear effect of dose
was not observed; increasing dose from LG to HG did
not result in an increased energy yield from exogenous
CHO (0.7, 1.0–2.4%, P = 1.00, ES = 0.16).
Compared with PLA (167.6  30.1 g), CHO ingestion
caused a moderate reduction in the absolute amount of
endogenous CHO oxidation with LG (33.3, 55.1 to
11.6 g, P = 0.32, ES = 1.18) and HG (21.6, 32.6 to
10.6 g, P = 0.10, ES = 0.80), as well as a large signifi-
cant reduction with LGF (48.0, 67.3 to 28.7,
P = 0.027, ES = 1.65) during the second hour of cycling.
However, the highest dose (HGF) had a similar, and
therefore not significantly different, reliance on endoge-
nous CHO oxidation compared with PLA (7.7, 24.5–
9.1 g, P = 1.00, ES = 0.24). A linear dose effect was there-
fore not observed for the absolute amount of endogenous
CHO oxidation during the second hour. However, in
LGF, endogenous CHO oxidation was significantly lower
than HG and HGF and despite not being significantly
lower than LG, produced an effect size of 0.54 (10.9%
mean reduction) (see Table 2 for comparisons).
The rate of plasma glucose oxidation (Fig. 3B) was not
significantly different between conditions during the sec-
ond hour of exercise. However, despite not being signifi-
cantly different, the higher rates of plasma glucose
oxidation for HGF and LGF compared with HG and LG
produced moderate differences at 60 min (P = 0.076–1.00,
ES = 0.59–1.06) and moderate or large effects at 90 and
120 min (P = 0.02–0.25, ES = 1.07–1.68). Differences
between LG and HG or LGF and HGF were all small and
not significant (P > 0.65, ES < 0.55). In addition, the
absolute contribution of plasma glucose to the total
Figure 1. (A) 13CO2:
12CO2 (d
13C) in expired air over the 2 h ride
and (B) 13C:12C in plasma glucose during the second hour of the
2 h ride. (a) denotes CHO significantly greater than PLA (P = 0.00–
0.047), (b) denotes HGF significantly greater than LG & HG
(P = 0.01 & 0.02), (c) denotes LGF significantly greater than LG &
HG (P = 0.0–0.024), (d) denotes LGF significantly greater than LG
and HG (P = 0.026–0.045), (e) denotes 90 min significantly greater
than 60 min.
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energy yield was not significantly different between LG
and HG, with a small effect size (Table 2). There were
also no significant differences between LGF and HGF.
However, the absolute difference in the amount of plasma
glucose oxidized was large and significantly higher for
LGF compared with LG, HG during the second hour of
exercise (Table 2).
There were no significant differences in the rate of liver
derived glucose between conditions (Fig. 3C) at any time
points. However, at 60 min, HG was moderately reduced
compared with LG (0.15, 0.28–0.02, P = 0.29,
ES = 0.92) and HGF (0.33, 0.02–0.64, P = 0.41,
ES = 0.88). At 90 min LGF was moderately reduced com-
pared with HGF (0.16, 0.02–0.30, P = 0.32, ES = 0.71,).
At the end of the 2-h ride (120 min), the rate of oxida-
tion of liver derived glucose was lowest with ingestion of
LGF (0.34  0.20 gmin1), a small but nonsignificant
reduction compared to HG (0.06, 0.15–0.04, P = 1.00,
ES = 0.39) and a moderate nonsignificant reduction com-
pared to LG (0.15, 0.27 to 0.02, P = 0.26,
ES = 0.58) and HGF (0.22, 0.46 to 0.01; P = 0.53,
ES = 0.68). There were also no significant differences in
the absolute oxidation (Table 2), or relative contributions
to the total energy yield of liver derived glucose (Fig. 2)
during the second hour of exercise (ES all 0.35–0.93).
However, despite not reaching significance, liver glucose
oxidation was moderately lower in LGF compared with
HGF in both the absolute oxidation of liver derived glu-
cose (11.2  17.7, 0.3–22.2 g, P = 0.46, ES = 0.79,) and
relative contribution to energy yield (3.3  5.0, 0.2–6.4%,
P = 0.41, ES = 0.93).
Muscle glycogen oxidation reduced throughout the sec-
ond hour of the 2-h ride, and was lowest with the inges-
tion of LGF (Fig. 3D). In this condition, muscle glycogen
oxidation reduced to 1.23  0.5 gmin1 at 120 min, a
moderate, but nonsignificant effect compared to LG
(0.45, 0.88 to 0.02 gmin1, P = 0.43, ES = 0.94), a
large significant effect to HG (0.56, 0.86 to
0.26 gmin1, P = 0.031, ES = 1.42) and a large and
nonsignificant effect to HGF (0.53, 0.87 to
0.19 gmin1, P = 0.08, ES = 1.42). Muscle glycogen
oxidation rate was also lowest in LGF at 60 (P = 0.072–
0.97, ES = 0.62–1.02) and 90 min (P = 0.76–1.00,
ES = 0.32–0.91), with moderate, but nonsignificant effects
to all CHO doses.
Furthermore, when considered over the whole second
hour, absolute muscle glycogen oxidation was lowest in
LGF compared with the other CHO conditions, with
effects ranging from small (8.7% reduction to LG) to
moderate (19.8% reduction to HG) and large (22.5%
reduction to HGF), but did not reach significant differ-
ences (See Table 2 for confidence intervals and ES). The
increased ingestion of both glucose-fructose and glucose
only resulted in higher absolute muscle glycogen oxida-
tion, that is, with glucose-fructose ingestion above
reported intestinal transport saturation, muscle glycogen
oxidation was increased and despite not reaching signifi-
cance, this effect was large. Similarly, when the dose of
glucose only was increased, absolute muscle glycogen oxi-
dation over the second hour increased. However, this
effect was not significant despite producing a moderate
effect (Table 2).
In terms of the relative contribution to energy yield
from muscle glycogen, these effects were magnified. Mus-
cle glycogen oxidation during the second hour of exercise
was significantly lower (with large effect sizes and signifi-
cant differences) for LGF compared with HGF (9.1,
4.9 to 13.4%, P = 0.01, ES = 1.68) and HG (9.6,
13.6 to 5.6, P = 0.01, ES = 1.76). Compared with LG,
the relative contribution of muscle glycogen oxidation to
the energy yield in LGF was also slightly lower, producing
a moderate, but nonsignificant difference (6.4, 13.3 to
0.5, P = 0.65, ES = 0.73,)
Circulatory metabolites and insulin
The response of plasma glucose, lactate and serum insulin
and FFA throughout the 2-h ride did not differ signifi-
cantly between CHO conditions (Fig. 4). Plasma lactate
concentrations after 15 min were similar, that is, not sig-
nificantly different, across all conditions
(2.5  1.6 mmolL1 to 3.1  2.2 mmolL1, P = 1.00,
ES < 0.30) and generally declined slightly, but not signifi-
cantly, over the 2-h ride (pooled average change, 0.4,
1.0 to 0.2, P = 1.00, ES = 0.29). Compared with the
ingestion of glucose only (LG and HG) the ingestion of
both glucose-fructose doses resulted in a small, but non-
significant, increase in plasma lactate concentration
throughout the 2-h ride (P = 1.00, ES = 0.26 & 0.28).
Plasma glucose concentrations increased in all condi-
tions from the start of exercise, peaking at 45 min in all
CHO conditions between 6.6  1.1 and
7.2  1.5 mmolL1. However, differences were small and
nonsignificant (P = 1.00, ES < 0.46), except in relation to
PLA, which was significantly lower (5.4  1.0 mmolL1;
P = 0.001–0.05, ES = 1.22–1.99,). Plasma glucose concen-
tration also peaked later in PLA, at 60 min, a moderate
effect to CHO ingestion, where concentrations were lower
than peak values (P = 0.02–1.00, ES = 0.49–1.05). From
75 min plasma glucose stabilized, producing small effects
of time in CHO conditions (P = 1.00, ES = 0.52–0.57)
and moderate nonsignificant effects between the highest
and lowest concentrations (HGF vs. LG) at 75 and
120 min (P = 0.39 & 0.06, ES = 0.79 & 0.87, respec-
tively). All other comparisons produced small nonsignifi-
cant effects (P = 1.00, ES < 0.54).
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Free fatty acid concentrations rose significantly throughout
the 2 h ride in PLA (P = 0.001, ES = 2.29), reaching a maxi-
mum value at the end of exercise (1.01  0.41 mmolL1).
CHO ingestion resulted in significantly lower FFA concentra-
tions compared with PLA, with large effects of mean
concentration (LG = 0.35  0.17, HG = 0.34  0.12,
LGF = 0.36  0.16, HGF = 0.31  0.16) compared with
PLA during the 2-h ride (P = 0.002–0.10, ES = 1.21–1.45)
and large and significant effects at 120 min (P = 0.004–0.05,
ES = 1.72–1.83). No CHO dose effects were apparent
(P = 1.00, ES < 0.38).
In PLA, serum insulin steadily declined over the 2-h
ride, but this was not significant (2.41 mUL1 decrease,
P = 0.84, ES = 1.09) and was elevated by CHO ingestion
(P < 0.05, ES > 1.00). After 15 min, serum insulin was
similar, that is, not significantly different, between
Table 2. Comparisons of CHO oxidation source during the second hour of exercise at 77% _VO2max
CHOox (g)
Difference in CHO oxidation (g)
LG HG LGF
Exogenous CHO
LG 41.2  10.8
HG 41.4  13.2 0.2, –3.0 to 3.4
ES = 0.02, P = 1.00
LGF 67.7  16.8 26.5, 19.4–33.7
ES = 1.76, P = 0.001
26.3, 19.9 to 32.8
ES = 1.87, P = 0.001
HGF 59.2  18.9 18.0, 10.3–25.7
ES = 1.10, P = 0.022
17.8, 9.5–26.0
ES = 1.16, P = 0.037
8.5, 14.9 to 2.2
ES = 0.48, P = 0.32
Endogenous CHO
LG 134.3  26.0
HG 146.0  23.2 11.7, 6.8 to 30.3
ES = 0.48, P = 1.00
LGF 119.6  28.1 14.7, –35.4 to 6.0
ES = 0.54, P = 1.00
26.4, 39.3 to 13.6
ES = 1.03, P = 0.048
HGF 160.0  33.8 25.7, 8.0–43.3
ES = 0.85, P = 0.247
14.0, 4.1 to 23.8
ES = 0.48, P = 0.26
40.4, 24.0 to 56.7
ES = 1.30, P = 0.017
Plasma glucose
LG 65.6  9.4
HG 62.3  14.5 3.3, –8.8 to 2.2
ES = 0.27, P = 1.00
LGF 87.0  19.1 21.4, 12.2–30.6
ES = 1.43, P = 0.024
24.7, 14.1 to 35.4
ES = 1.46, P = 0.024
HGF 89.7  32.1 24.1, 7.2–41.0
ES = 1.02, P = 0.26
27.4, 10.4 to 44.3
ES = 1.10, P = 0.16
2.7, 9.8–15.1
ES = 0.10, P = 1.00
Liver glycogen
LG 24.4  10.1
HG 20.9  5.6 3.5, 8.7 to 1.6
ES = 0.43, P = 1.00
LGF 19.3  9.4 5.1, 10.6 to 0.3
ES = 0.53, P = 0.90
1.6, 7.9 to 4.7
ES = 0.21, P = 1.00
HGF 30.5  17.7 6.1, 4.6 to 17.0
ES = 0.42, P = 1.00
9.6, 1.4 to 20.6
ES = 0.73, P = 0.90
11.2, 2.0–20.4
ES = 0.79, P = 0.46
Muscle glycogen
LG 109.9  26.9
HG 125.1  24.8 15.2, 3.6 to 34.2
ES = 0.60, P = 1.00
LGF 100.3  23.1 9.6, 27.1 to 8.1
ES = 0.38, P = 1.00
24.8, 37.2 to 12.4
ES = 1.04, P = 0.056
HGF 129.5  22.6 19.6, 6.6 to 32.6
ES = 0.79, P = 0.21
4.4, 4.9 to 13.6
ES = 0.18, P = 1.00
29.2, 14.3–44.0
ES = 1.28, P = 0.062
Values given are comparisons of CHO oxidation from various sources over the second hour of the 2 h ride between LG (60 gh1), HG
(75 gh1), LGF (90 gh1) and HGF (112.5 gh1). [first line: mean  SD, absolute difference between conditions with associated 95% confi-
dence intervals; second line: Cohen’s d effect size and P value (ANOVA with Bonferroni post hoc comparison)]. N = 11.
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conditions (P > 0.18, ES < 0.45) and peaked at 45 min in
all CHO conditions, except in LGF (see Fig. 4). Increasing
CHO dose did not alter serum insulin beyond a moderate,
nonsignificant effect at any time point (ES < 1.01) until
the end of exercise where a significant large effect was
seen between LG and HGF (P = 0.01, ES = 1.61,) and
moderate (nonsignificant) effects between LG and HG &
LGF (P = 0.50 and 0.53, ES = 0.94 and 0.95).
Time trial performance
The effect of CHO ingestion was to increase mean power
output during the 30-min time trial compared with pla-
cebo (Table 3). With a change in performance of 1.2%
used as the smallest meaningful improvement, the inges-
tion of CHO was at least 81% “likely” to 99% “almost
certain” to improve the chance of increasing mean power
output. The chances of CHO ingestion causing a detri-
mental effect were less than 8% “unlikely/probably not”
Figure 2. Percentage energy contributions from various substrates
during the second hour of the 2 h ride. (a) denotes LGF
significantly different to LG (P = 0.00), (b) denotes LGF significantly
different to HG (P = 0.00–0.019), (c) denotes LGF significantly
different to HGF (P = 0.014)
Figure 3. Sources of oxidised glucose and muscle glycogen during the second hour of the ride. A: Carbohydrate from exogenous sources
(g.min1) B: Plasma glucose oxidation (g.min1) C & D: Liver and Muscle glycogen oxidation respectively (g.min1) Data are means  sd. a
denotes LGF significantly lower than HG
2018 | Vol. 6 | Iss. 1 | e13555
Page 10
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion A. J. King et al.
to happen in HG, and <2% “very unlikely” in all other
CHO conditions. Significantly, the ingestion of 90 gh1
glucose-fructose (LGF) resulted in the highest mean
power output, producing a greater than 93% “likely/prob-
able” chance of improved time trial performance com-
pared to the other CHO doses. There was no linear dose
relationship between CHO dose and time trial perfor-
mance, however, and the chances of improving perfor-
mance by increasing both single and multiple CHO doses
were “unlikely” or “very unlikely” beneficial (74% “possi-
ble” detrimental effect and a 91% “likely/probably” detri-
mental effect, respectively for LG vs. HG and LGF vs.
HGF).
Discussion
This study has demonstrated that the ergogenic effect of
CHO ingestion during prolonged exercise is sensitive to
dose and that the ingestion of 90 gh1 glucose-fructose
was optimal when compared with lower doses of glucose
(60 and 75 gh1) and a higher dose of glucose-fructose
(112.5 gh1). Ingestion of 90 gh1 glucose-fructose pro-
duced the largest oxidation of exogenous CHO which led
to an attenuation of pre-existing muscle glycogen use,
with smaller alterations in the oxidation of glucose
released from the liver. This has the potential to produce
improvements in a subsequent time trial performance fol-
lowing a 2 h fixed load ride compared to the other CHO
doses and the placebo. This study also demonstrates an
“over-dose” effect of intestinal CHO transporters for the
high dose glucose-fructose condition compared with one
at saturation limits for SGLT1 and GLUT5., There was an
increased reliance on liver and muscle glycogen with
112.5 gh1 of glucose-fructose, with no further oxidation
of exogenous CHO. This was seen with a concurrent
reduction in fat oxidation. Therefore, a novel aspect of
Figure 4. Circulatory metabolites, plasma glucose and lactate, serum-free fatty acids and insulin concentrations during the 2 h ride. Data are
means  SD. See text for statistical and ES comparisons.
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this study is that the manipulation of CHO dose at and
above intestinal CHO transport limits can have a poten-
tially meaningful impact on endogenous fuel use and sub-
sequent time trial performance.
The ingestion of glucose-fructose resulted in a higher
peak rate of exogenous CHO oxidation (1.33 gmin1)
than with glucose alone (0.88 gmin1), which is consis-
tent with the existing literature (Jentjens et al. 2005;
Smith et al. 2010). This study adds further support for
the efficacy of using MTC to maximize exogenous CHO
oxidation, (Jentjens et al. 2004a, b; Jeukendrup et al.
2006; Hulston and Jeukendrup 2008; Rowlands and
Clarke 2011). As the rate of cellular glucose uptake is not
rate limiting in the normal physiological range of plasma
glucose concentration with CHO ingestion (Hawley et al.
1994), using MTC maximizes intestinal CHO transport
by concurrently using both SGLT1 and GLUT-5 transport
proteins, increasing the availability of CHO for oxidation,
which explains the difference in the rates of exogenous
CHO oxidation. This study further supports the evidence
(Jentjens et al. 2004b, 2006; Jentjens and Jeukendrup
2005; Wallis et al. 2007) that when ingesting glucose or
glucose-fructose, that increasing the dose beyond intesti-
nal saturation of SGLT1 and GLUT-5 transport proteins
provides no further increases in exogenous CHO oxida-
tion. This is likely due to an accumulation of the CHO in
the gut (Jeukendrup and Moseley 2010). This delay in
CHO absorption across the intestinal lumen may explain
the moderately reduced relative contribution of exogenous
CHO to the total energy yield in HGF compared with
LGF when these data are considered for the whole of the
second hour of exercise, rather than just the peak oxida-
tion rates. It should be noted that a recent review high-
lights potential individual variability in exogenous CHO
oxidation rates with fructose (co)ingestion, and at inges-
tion rates approximate or lower than 0.5–0.6 gmin1 for
fructose, the ratio of fructose to glucose ingestion may
exceed that reported in this study (Rowlands et al. 2015).
The current study also partially supports previous evi-
dence that maintaining high rates of exogenous glucose
oxidation, seen with elevated plasma glucose concentra-
tions, may explain the ergogenic benefit of CHO ingestion
during prolonged exercise (Coyle et al. 1986; Jeukendrup
et al. 2006). In the present study glucose-fructose inges-
tion only marginally resulted in higher plasma glucose
concentrations than glucose ingestion, but both ingestion
of glucose and glucose-fructose significantly increased
plasma glucose concentrations compared with placebo.
While plasma glucose concentrations do not reflect rates
of glucose flux (i.e., rates of appearance and disappear-
ance of circulatory glucose), the current exogenous CHO
glucose oxidation data provide evidence for a greater dis-
posal of glucose into the working muscle in the LGF con-
dition. Therefore, the proposed mechanism of increasing
CHO as a substrate to the working muscle may have an
upper limit in its effect, as demonstrated by the differing
time trial performances with low and high glucose-fruc-
tose conditions.
Small alterations in exogenous CHO oxidation will
alter endogenous substrate oxidation where the energy
cost of exercise is unchanged. Due to the finite energy
resource that glycogen stores provide, it stands that
Table 3. Comparison of performance and changes in performance in the 30 minute time trial following 2 h of exercise at 77% _VO2max
Performance (W)
% Improvement in average power
LG HG LGF HGF



























LGF 225  45 5.1, 0.2–9.8 (0.27)
2%, probably not
P = 0.11
HGF 213  43
Data are: mean power outputs during the 30-minute time trial with ingestion of LG (60 gh1), HG (75 gh1), LGF (90 gh1) and HGF
(112.5 gh1) (mean  SD). [first line: % difference between conditions following log transformation of data with associated 90% confidence
intervals; second line: Cohen’s d effect size (in parentheses); third line: chances of (% and qualitative) of meaningful improvement; fourth line:
P value from ANOVA with LSD post hoc comparison]. N = 11.
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attenuating muscle glycogen use should produce a posi-
tive performance benefit, particularly in cycling where
power generation is more localized and effective muscle
glycogen availability reduced (Arkinstall et al. 2001). This
is the first study to show that an increase in glucose-fruc-
tose dose from 90 to 112.5 gh1 caused a greater reliance
(large effect) on pre-existing muscle glycogen. This was
associated with a concomitant reduction in oxidation of
fat, even though there was no significant difference in
absolute exogenous CHO oxidation. However, a small dif-
ference in the absolute amount of exogenous CHO oxida-
tion (8.5 g) during the last hour of exercise for HGF
compared with LGF, could be considered meaningful
based on the confidence intervals (Table 2). Therefore, it
is interesting that this lower absolute amount of exoge-
nous CHO oxidation was not equivalent to the absolute
increase in endogenous glycogen observed between 90
and 112.5 gh1 (40.4 g, large effect); this was predomi-
nately from pre-existing muscle glycogen (large effect),
rather than glucose released from the liver (moderate
effect). This provides evidence from a fuel use perspective,
on why individuals should not consume excessively high
doses of CHO during endurance exercise, where the avail-
ability of CHO may become limited. In addition, when
glucose was ingested alone, there was a moderate increase
in the use of pre-existing muscle glycogen when the dose
was increased above the reported limit for SGLT1, albeit
smaller compared with glucose-fructose. Even though this
did not affect fat oxidation, an increase in the use of pre-
existing muscle glycogen for the high dose of glucose is
“probably” likely to negatively affect subsequent time trial
performance, compared with a dose of glucose at intesti-
nal absorption rates. In addition, glucose-fructose in com-
parison with glucose ingestion at the previously reported
saturation limits (60 gh1), was more effective at attenu-
ating muscle glycogen utilization. Even though this effect
was small, it may be part of the explanation for better
performance on LGF compared with LG. Taken together,
this leads to the conclusion that in terms of muscle glyco-
gen oxidation, the rate of ingestion should reach, but not
exceed, or “over-dose” intestinal saturation transporters
for either glucose (Wallis et al. 2007) or glucose-fructose
use.
These data from the current study shows that muscle
glycogen oxidation is increased when CHO ingestion rates
exceed intestinal transport rates, which in the case of
HGF was associated with a decrease in fat oxidation. This
decrease in fat oxidation is not, however, supported by
the FFA concentration data, which were similar between
conditions during exercise. However, adipose tissue FFA
release will likely have been suppressed by the moderately
elevated insulin concentrations relative to the other con-
ditions (Coyle et al. 1997). The higher circulatory insulin
was likely to have inhibited hormone sensitive lipase, sup-
pressing FFA release which is not accounted for in FFA
concentrations due to the flux between the circulating
substrate and cellular (muscle) uptake. Nevertheless, it is
possible that the lack of differences in the FFA concentra-
tions and the moderately increased insulin concentrations
with 112.5 gh1 of glucose-fructose reflect a reduction in
IMTG oxidation where carnitine palmitoyl transferase 1
(CPT-1) and subsequent long chain FA are inhibited
(Jeppesen and Kiens 2012). This may in part explain the
increased reliance on muscle glycogen as a muscle energy
substrate.
The release of glucose from the liver during the 2-h
cycle made a relatively small contribution to the total
energy yield compared to that from muscle glycogen.
However, the ingestion of 90 gh1 glucose-fructose has
shown a moderate (but nonsignificant) attenuation of
liver glycogen oxidation in comparison with 112.5 gh1,
but small in comparison with the two glucose doses,
which may be important in terms of exercise perfor-
mance. However, caution is required, as the large individ-
ual variation in this study make these data difficult to
interpret. It is possible that previous evidence of sparing
whole body endogenous glycogen (calculated as the differ-
ence between total CHO oxidation measured by indirect
calorimetry and exogenous glucose oxidation), (Jentjens
et al. 2004a; Jentjens and Jeukendrup 2005; Wallis et al.
2006; Pfeiffer et al. 2011) may be mediated by attenua-
tions in hepatic glucose production, that is, a sparing of
liver glycogen, as high CHO doses can dramatically
reduce hepatic glucose output (Jeukendrup et al. 1999;
Wallis et al. 2006). However, it is noteworthy in this
study, that the release of glucose from the liver was high-
est for 112.5 gh1 of glucose-fructose compared with
lower doses of glucose and glucose-fructose. Therefore,
further dose response studies are required to establish the
optimal effect on liver glycogen oxidation, which has been
deemed important for sustaining endurance performance.
However, it is worth noting that the dose (~180 gh1)
used in the former of these studies may have excessively
over saturated or “over-dosed” the intestinal SGLT1
transport protein, and are impractical as “real-world”
ingestion rates (Jeukendrup et al. 1999). Liver glycogen
sparing has also been seen when just above saturation
(102 gh1;(Gonzalez et al. 2015)) following the ingestion
of sucrose. In both studies, it would have been interesting
to see whether a lower dose of carbohydrate would have
produced better attenuation of liver glycogen oxidation,
as observed in this study.
Liver glycogen reserves also form a small contribution
to overall glycogen capacity and following an overnight
fast, are likely to be in the region of 60 g (Magnusson
et al. 1992). Therefore, under the assumption (as the 13C
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isotope tracer methodology cannot reliably determine oxi-
dation rates in the first hour of exercise) that liver glyco-
gen oxidation rates are similar to the second hour, liver
glycogen may have been near depletion at the end of
exercise in the HGF condition. Whether high rates of
liver glycogen oxidation or close to depleted reserves are
likely to directly influence exercise capacity in terms of
fatigue requires further mechanistic elucidation. However,
the association between hypoglycemia and exercise capac-
ity is well established (Coyle and Coggan 1984) with liver
glycogen playing an important role in sustaining endur-
ance performance (Casey et al. 2000). It should be noted
that the current methodology cannot differentiate
between glucose derived from liver glycogen, or glucose
derived from gluconeogenic precursors, which may con-
tribute 0.11  0.05 gmin1 of glucose production during
prolonged exercise at the lactate threshold in well trained
cyclists (Emhoff et al. 2013). It should also be noted that
the plasma 13C:12C with fructose ingestion (i.e., with 13C
labeled fructose) may be slightly diminished by the “loss”
of 13C signal due to hepatic conversion of fructose to lac-
tate. Under these possible conditions a number of 13C
atoms will be attached to newly formed lactate and as
such not measured by IRMS. Therefore, it is possible that
the subsequently derived muscle and liver glycogen oxida-
tion values will be over and under estimated, respectively.
However, this is an area that warrants future research, as
recent data suggest that the appearance of circulating lac-
tate is not significantly different between glucose-fructose
and water ingestion. Furthermore, and despite similar
plasma lactate concentrations in this study, fructose inges-
tion can cause an increase in lactate concentrations
(LeCoultre et al. 2010) and the rate of appearance of lac-
tate with fructose ingestion during exercise is elevated.
However, the methodology used by LeCoultre et al.
(2010) cannot apportion the source of lactate production
between the possible liver conversion or the conversion of
fructose derived glucose which has subsequently under-
gone oxidation in the contracting muscle.
In this study, improvements in TT performance were
not linear with increasing CHO dose. In fact, for both
glucose only and glucose-fructose ingestion, there was an
“over-dose” effect, whereby performance was reduced
when CHO doses were ingested in excess of the reported
intestinal saturation rates. In this regard, and in agree-
ment with the literature, glucose-fructose mixtures are
more beneficial to prolonged exercise performance (Cur-
rell and Jeukendrup 2008; Baur et al. 2014). Whilst dose
response literature to this effect is scarce, Smith et al.
(2013) showed endurance performance follows a curvi-
linear response to increasing CHO dose, modeling opti-
mal performance in a 20 km time trial following 2 h of
constant load work with 68–88 gh1 of glucose-fructose
ingestion. However, the study did not report fuel use
data and therefore a unique aspect of this study is the
finding that the use of pre-existing muscle glycogen was
also attenuated during the 2 h ride with the ingestion of
a 90 gh1 glucose-fructose solution, which may in part
explain the greater mean power output during the sub-
sequent TT in this condition. Therefore, our data also
provide evidence to suggest the total rate of exogenous
CHO oxidation may not provide a single ergogenic
explanation as an additional benefit of “sparing” muscle
glycogen with the ingestion of 90 gh1 glucose-fructose
was also seen.
In conclusion, ingestion of 90 gh1 glucose and fructose
is recommended for prolonged (>2 h) exercise perfor-
mance due to the potential to spare muscle glycogen oxida-
tion relative to lower doses of single CHO ingestion, and
higher MTC ingestion. This falls in line with previous evi-
dence in regards to performance, but provides new insight
into the liver and muscle glycogen response to exercise of
this nature. Ingesting high amounts of either single or mul-
tiple source CHO also creates an “over-dose” effect,
whereby effective and beneficial muscle glycogen oxidation
and exercise performance are diminished. Therefore, it
should be recommended that the rate of ingestion should
reach, but not exceed intestinal saturation for either glucose
or glucose-fructose ingestion. The mechanism(s) behind
the ergogenic effect of CHO in endurance exercise are likely
more complex than being related to a single factor and data
from this study suggest that the effect of CHO ingestion
may be both dose dependent and integral to protecting
finite glycogen stores which may play a key role in regulat-
ing fatigue and prolonged exercise. Further research is war-
ranted to confirm these effects in more prolonged exercise,
and to investigate the cellular signaling pathways that to
which this effect may be attributable.
Acknowledgments
The authors thank Vanessa James for her help with data
collection and Eleanor McKay and Sandra Small for their
expertise in stable isotope analysis.
Conflicts of Interest
The authors declare no conflicts of interest. In submission
of this paper, the authors declare that the results of the
study are presented clearly, honestly, and without fabrica-
tion, falsification, or inappropriate manipulation of data.
References
Adopo, E., F. Peronnet, D. Massicotte, G. Brisson, and C.
Hillaire-Marcel. 1994. Respective oxidation of exogenous
2018 | Vol. 6 | Iss. 1 | e13555
Page 14
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion A. J. King et al.
glucose and fructose given in the same drink during
exercise. J. Appl. Physiol. 76:1014–1019.
Arkinstall, M., C. Bruce, V. Nikolopoulos, A. Garnham, and J. A.
Hawley. 2001. Effect of carbohydrate ingestion on metabolism
during running and cycling. J. Appl. Physiol. 91:2125–2134.
Baur, D. A., A. B. Schroer, N. D. Luden, C. J. Womack, S. A.
Smyth, and M. J. Saunders. 2014. Glucose-fructose enhances
performance versus isocaloric, but not moderate, glucose.
Med. Sci. Sports Exerc. 46:1778–1786.
Brooks, G. A. 1986. Lactate production under fully aerobic
conditions: the lactate shuttle during rest and exercise. Fed.
Proc. 45:2924–2929.
Casey, A., R. Mann, K. Banister, J. Fox, P. Morris, I.
Macdonald, et al. 2000. Effect of carbohydrate ingestion on
glycogen resynthesis in human liver and skeletal muscle,
measured by (13)C MRS. Am. J. Physiol. Endocrinol.
Metab. 278:E65–E75.
Constantin-Teodosiu, D., A. Casey, A. Short, E. Hultman, and
P. Greenhaff. 1996. The effect of repeated muscle biopsy
sampling on ATP and glycogen resynthesis following
exercise in man. Eur. J. Appl. Physiol. 73:186–190.
Coyle, E. F., and A. Coggan. 1984. Effectiveness of
carbohydrate feeding in delaying fatigue during prolonged
exercise. Sports Med. 1:446–458.
Coyle, E., A. Coggan, M. Hemmert, and J. L. Ivy. 1986. Muscle
glycogen utilization during prolonged strenuous exercise
when fed carbohydrate. J. Appl. Physiol. 61:165–172.
Coyle, E., A. Jeukendrup, A. Wagenmakers, and W. Saris.
1997. Fatty acid oxidation is directly regulated by
carbohydrate metabolism during exercise. Am. J. Physiol.
Endocrinol. Metab. 273:E268–E275.
Craig, H. 1953. The geochemistry of the stable carbon
isotopes. Geochim. Cosmochim. Acta. 3:53–92.
Craig, H. 1957. Isotopic standards for carbon and oxygen and
correction factors for mass-spectrometric analysis of carbon
dioxide. Geochim. Cosmochim. Acta 12:133–149.
Currell, K., and A. E. Jeukendrup. 2008. Superior endurance
performance with ingestion of multiple transportable
carbohydrates. Med. Sci. Sports Exerc. 40:275–281.
Emhoff, C. A., L. A. Messonnier, M. A. Horning, J. A. Fattor,
T. J. Carlson, and G. A. Brooks. 2013. Gluconeogenesis and
hepatic glycogenolysis during exercise at the lactate
threshold. J. Appl. Physiol. 114:297–306.
Frayn, K. N. 1983. Calculation of substrate oxidation rates
in vivo from gaseous exchange. J. Appl. Physiol. 55:628–
634.
Gonzalez, J., C. Fuchs, F. Smith, P. E. Thelwall, R. Taylor, E. J.
Stevenson, et al. 2015. Ingestion of glucose or sucrose
prevents liver but not muscle glycogen depletion during
prolonged endurance-type exercise in trained cyclists. Am. J.
Physiol. Endocrinol. Metab. 309:E1032–E1039.
Hargreaves, M., D. Costill, A. Coggan, W. Fink, and I.
Nishibata. 1984. Effect of CHO feedings on muscle gly
utilisation and exercise performance. Med. Sci. Sports Exerc.
16:219–222.
Harvey, C., R. Frew, D. Massicotte, F. Peronnet, and N. J.
Rehrer. 2007. Muscle glycogen oxidation during prolonged
exercise measured with oral [13C]glucose: comparison with
changes in muscle glycogen content. J. Appl. Physiol.
102:1773–1779.
Hawley, J. A., A. Bosch, S. Weltan, S. Dennis, and T. Noakes.
1994. Effects of glucose ingestion or glucose infusion on fuel
substrate kinetics during prolonged exercise. Eur. J. Appl.
Physiol. 68:381–389.
Hopkins, M., J. A. Hawley, and L. Burke. 1999. Design and
analysis of research on sport performance enhancement.
Med. Sci. Sports Exerc. 41:472–485.
Hopkins, W., S. Marshall, A. Batterham, and J. Hanin. 2009.
Progressive statistics for studies in sports medicine and
exercise science. Med. Sci. Sports Exerc. 41:3–12.
Hulston, C. J., and A. Jeukendrup. 2008. Substrate metabolism
and exercise performance with caffeine and carbohydrate
intake. Med. Sci. Sports Exerc. 40:2096–2104.
Jentjens, R., and A. Jeukendrup. 2005. High rates of exogenous
carbohydrate oxidation from a mixture of glucose and
fructose ingested during prolonged cycling exercise. Br. J.
Nutr. 93:485–492.
Jentjens, R., J. Achten, and A. Jeukendrup. 2004a. High
oxidation rates from combined carbohydrates ingested
during exercise. Med. Sci. Sports Exerc. 36:1551–1558.
Jentjens, R., L. Moseley, R. Waring, L. Harding, and A.
Jeukendrup. 2004b. Oxidation of combined ingestion of
glucose and fructose during exercise. J. Appl. Physiol.
96:1277–1284.
Jentjens, R., C. Shaw, T. Birtles, R. Waring, L. Harding, and A.
Jeukendrup. 2005. Oxidation of combined ingestion of
glucose and sucrose during exercise. Metabolism 54:610–
618.
Jentjens, R., K. Underwood, J. Achten, K. Currell, C. Mann,
and A. Jeukendrup. 2006. Exogenous carbohydrate oxidation
rates are elevated after combined ingestion of glucose and
fructose during exercise in the heat. J. Appl. Physiol.
100:807–816.
Jeppesen, J., and B. Kiens. 2012. Regulation and limitations to
fatty acid oxidation during exercise. J. Physiol. 590:1059–
1068.
Jeukendrup, A. 2014. A step towards personalized sports
nutrition: carbohydrate intake during exercise. Sports Med.
44(Suppl 1):S25–S33.
Jeukendrup, A., and L. Moseley. 2010. Multiple transportable
carbohydrates enhance gastric emptying and fluid delivery.
Scand. J. Med. Sci. Sports 20:112–121.
Jeukendrup, A., A. Wagenmakers, J. Stegen, A. Gijsen, and W.
Saris. 1999. Carbohydrate ingestion can completely suppress
endogenous glucose production during exercise. Am. J.
Physiol. Endocrinol. Metab. 276:E672–E683.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2018 | Vol. 6 | Iss. 1 | e13555
Page 15
A. J. King et al. Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion
Jeukendrup, A., L. Moseley, G. Mainwaring, S. Samuels, S.
Perry, and C. Mann. 2006. Exogenous carbohydrate
oxidation during ultraendurance exercise. J. Appl. Physiol.
100:1134–1141.
Kuipers, H., F. Verstappen, H. Keizer, P. Geurten, and G. van
Kranenburg. 1985. Variability of aerobic performance in the
laboratory and its physiologic correlates. Int. J. Sports Med.
6:197–201.
LeCoultre, A., R. Benoit, G. Carrel, Y. Schutz, G. Millet, L.
Tappy, et al. 2010. Fructose and glucose co-ingestion during
prolonged exercise increases lactate and glucose fluxes and
oxidation compared with an equimolar intake of glucose.
Am. J. Clin. Nutr. 92:1071–1079.
Magnusson, I., D. Rothman, L. Katz, R. Schulman, and G.
Schulman. 1992. Increased rate of gluconeogenesis in type II
diabetes mellitus. A 13C nuclear magnetic resonance study.
J. Clin. Invest. 90:1323–1327.
Maughan, R. J., L. Bethell, and J. Leiper. 1996. Effects of
ingested fluids on exercise capacity and on cardiovascular
and metabolic responses to prolonged exercise in man. Exp.
Physiol. 81:847–859.
McConell, G. K., R. J. Snow, J. Proietto, and M. Hargreaves.
1999. Muscle metabolism during prolonged exercise in
humans- influence of carbohydrate availability. J. Appl.
Physiol. 87:1083–1086.
Morrison, D., B. Dodson, C. Slater, and T. Preston. 2000. 13C
natural abundance in the british diet-implications for 13C
breath tests. Rapid Commun. Mass Spectrom. 14:1321–1324.
Morrison, D. J., J. P. O’Hara, R. F. King, and T. Preston.
2011. Quantitation of plasma 13C-galactose and 13C-
glucose during exercise by liquid chromatography/isotope
ratio mass spectrometry. Rapid Commun. Mass Spectrom.
25:2484–2488.
O’Brien, W., and D. Rowlands. 2011. Fructose-maltodextrin
ratio in a carbohydrate-electrolyte solution differentially
affects exogenous carbohydrate oxidation rate, gut comfort,
and performance. Am. J. Physiol. Gastrointest. Liver Physiol.
300:G181–G189.
Pallikarakis, N., N. Sphiris, and P. Lefebvre. 1991. Influence of
the bicarbonate pool and on the occurence of 13CO2 in
exhaled air. Eur. J. Appl. Physiol. 63:179–183.
Peronnet, F., D. Massicotte, G. Brisson, and C. Hillaire-Marcel.
1990. Use of 13C substrates for metabolic studies in exercise:
methodological considerations. J. Appl. Physiol. 69:1047–
1052.
Peronnet, F., N. Rheaume, C. Lavoie, C. Hillaire-Marcel, and
D. Massicotte. 1998. Oral [13C]glucose oxidation during
prolonged exercise after high- and low-carbohydrate diets. J.
Appl. Physiol. 85:723–730.
Pfeiffer, B., T. Stellingwerff, E. Zaltas, A. B. Hodgson, and A.
E. Jeukendrup. 2011. Carbohydrate oxidation from a drink
during running compared with cycling exercise. Med. Sci.
Sports Exerc. 43:327–334.
Robert, J., J. Loziet, D. Chauvet, D. Darmaun, J. Desjeux, and
V. Young. 1987. Use of 13C-labeled glucose for estimating
glucose oxidation: some design considerations. J. Appl.
Physiol. 63:1725–1732.
Rowlands, D. S., and J. Clarke. 2011. Lower oxidation of a
high molecular weight glucose polymer vs. glucose during
cycling. Appl. Physiol. Nutr. Metab. 36:298–306.
Rowlands, D. S., M. S. Thorburn, R. M. Thorp, S. Broadbent,
and X. Shi. 2008. Effect of graded fructose coingestion with
maltodextrin on exogenous 14C-fructose and 13C-glucose
oxidation efficiency and high-intensity cycling performance.
J. Appl. Physiol. 104:1709–1719.
Rowlands, D., S. Houltham, K. Musa-Veloso, F. Brown, L.
Paulionis, and D. Bailey. 2015. Fructose-glucose composite
carbohydrates and endurance performance: critical review
and future perspectives. Sports Med. 45:1561–1576.
Shi, X., R. Summers, H. Schedl, S. Flanagan, R. Chang, and C.
Gisolfi. 1995. Effects of carbohydrate type and concentration
and solution osmolality on water absorption. Med. Sci.
Sports Exerc. 27:1607–1615.
Smith, J. W., J. J. Zachwieja, F. Peronnet, D. H. Passe, D.
Massicotte, C. Lavoie, et al. 2010. Fuel selection and cycling
endurance performance with ingestion of [13C]glucose:
evidence for a carbohydrate dose response. J. Appl. Physiol.
108:1520–1529.
Smith, J. W., D. D. Pascoe, D. H. Passe, B. C. Ruby, L. K.
Stewart, L. B. Baker, et al. 2013. Curvilinear dose-response
relationship of carbohydrate (0-120 g.h(-1)) and
performance. Med. Sci. Sports Exerc. 45:336–341.
Stellingwerff, T., and G. R. Cox. 2014. Systematic review:
carbohydrate supplementation on exercise performance or
capacity of varying durations. Appl. Physiol. Nutr. Metab.
39:998–1011.
Stellingwerff, T., H. Boon, A. P. Gijsen, J. H. Stegen, H.
Kuipers, and L. J. van Loon. 2007. Carbohydrate
supplementation during prolonged cycling exercise spares
muscle glycogen but does not affect intramyocellular lipid
use. Pflugers Arch. 454:635–647.
Trimmer, J., A. Casazza, M. A. Horning, and G. A. Brooks.
2001. Recovery of 13CO2 during rest and exercise after
[1-13C]acetate, [2-13C]acetate, and NaH13CO3 infusions.
Am. J. Physiol. Endocrinol. Metab. 281:E683–E692.
Tripplett, D., A. Doyle, J. Rupp, and D. Benardot. 2010. An
isocaloric glucose-fructose beverage’s effect on simulated
100-km cycling performance compared with a glucose-only
beverage. Int J Sport Nutr Exerc. Metab. 20:122–131.
Tsintzas, K., C. Williams, L. Boobis, and P. Greenhaff. 1995.
Carbohydrate ingestion and glycogen utilization in different
muscle fibre types in man. J. Physiol. 489:243–250.
Tsintzas, K., C. Williams, L. Boobis, and P. Greenhaff. 1996.
Carbohydrate ingestion and single muscle fiber glycogen
metabolism during prolonged running in men. J. Appl.
Physiol. 81:801–809.
2018 | Vol. 6 | Iss. 1 | e13555
Page 16
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion A. J. King et al.
Tsintzas, K., C. Williams, D. Constantin-Teodosiu, E.
Hultman, L. Boobis, P. Clarys, et al. 2001. Phosphocreatine
degradation in type I and type II muscle fibres during
submax exercise. J. Physiol. 537:305–311.
Van Loon, L. J., P. Greenhaff, D. Constantin-Teodosiu, W.
Saris, and A. Jeukendrup. 2001. The effects of increasing
exercise intensity on muscle fuel utilisation in humans. J.
Physiol. 536:295.
Van Thienen, R., G. D’Hulst, L. Deldicque, and P. Hespel.
2014. Biochemical artifacts in experiments involving
repeated biopsies in the same muscle. Physiol. Rep. 2:
e00286.
Wallis, G. A., R. Dawson, J. Achten, J. Webber, and A. E.
Jeukendrup. 2006. Metabolic response to carbohydrate
ingestion during exercise in males and females. Am. J.
Physiol. Endocrinol. Metab. 290:E708–E715.
Wallis, G. A., S. E. Yeo, A. K. Blannin, and A. E. Jeukendrup.
2007. Dose-response effects of ingested carbohydrate on
exercise metabolism in women. Med. Sci. Sports Exerc.
39:131–138.
Yaspelkis, B., J. Patterson, P. Anderla, S. Ding, and J. L. Ivy.
1993. Carbohydrate supplementation spares muscle glycogen
during variable-intensity exercise. J. Appl. Physiol. 75:1477–
1485.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2018 | Vol. 6 | Iss. 1 | e13555
Page 17
A. J. King et al. Liver and Muscle Glycogen Oxidation with Carbohydrate Ingestion
